Ibrexafungerp in the Treatment of Vulvovaginal Candidiasis.
Kylie N BarnesAbigail M YanceyAlicia B ForinashPublished in: The Annals of pharmacotherapy (2022)
Ibrexafungerp, a recently approved triterpenoid antifungal agent, is an effective and well-tolerated option for the treatment of VVC.
Keyphrases